APA (7th ed.) Citation

FD, W., YH, C., HC, C., TY, O., MH, L., PA, N., . . . JC, H. (2025). Nirmatrelvir-ritonavir significantly reduces severe COVID-19 outcomes in diverse Taiwanese populations: Comprehensive evidence from a large-scale longitudinal cohort study in Taiwan. Journal of infection and public health, 18(6), 102760. https://doi.org/10.1016/j.jiph.2025.102760

Chicago Style (17th ed.) Citation

FD, Wang, et al. "Nirmatrelvir-ritonavir Significantly Reduces Severe COVID-19 Outcomes in Diverse Taiwanese Populations: Comprehensive Evidence from a Large-scale Longitudinal Cohort Study in Taiwan." Journal of Infection and Public Health 18, no. 6 (2025): 102760. https://doi.org/10.1016/j.jiph.2025.102760.

MLA (9th ed.) Citation

FD, Wang, et al. "Nirmatrelvir-ritonavir Significantly Reduces Severe COVID-19 Outcomes in Diverse Taiwanese Populations: Comprehensive Evidence from a Large-scale Longitudinal Cohort Study in Taiwan." Journal of Infection and Public Health, vol. 18, no. 6, 2025, p. 102760, https://doi.org/10.1016/j.jiph.2025.102760.